Information  X 
Enter a valid email address

Scancell Holdings PLC Ord 0.1P (SCLP)

Date Time Source Announcement
18 May 2015 7:00 am
RNS
Update on SCIB1 data at 2015 ASCO Annual Meeting
17 Apr 2015 9:00 am
RNS
Poster on Moditope to be presented at AACR
24 Mar 2015 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
SCIB2 synergy with checkpoint inhibitor blockade
12 Jan 2015 7:00 am
RNS
Positive SCIB1 Phase 1/2 clinical trial update
15 Dec 2014 5:22 pm
RNS
Holding(s) in Company
10 Dec 2014 7:00 am
RNS
Half Yearly Report
22 Oct 2014 3:07 pm
RNS
Change of Registered Office
14 Oct 2014 6:19 pm
RNS
Result of AGM
  7:00 am
RNS
Appointment of Nominated Adviser and Broker
  7:00 am
RNS
AGM research and development update
30 Sep 2014 7:00 am
RNS
Present at the 14th Annual Biotech in Europe Forum
19 Sep 2014 9:57 am
RNS
Notice of AGM
12 Sep 2014 7:00 am
RNS
Presenting at Upcoming Scientific Conferences
04 Sep 2014 7:00 am
RNS
Final Results
12 Aug 2014 7:00 am
RNS
Synergy of SCIB1 with checkpoint inhibitors
19 Jun 2014 7:00 am
RNS
Director/PDMR Shareholding
06 Jun 2014 7:00 am
RNS
DNA ImmunoBody Patent Granted in United States
02 Jun 2014 7:00 am
RNS
Update on Phase 1/2 trial of SCIB1 in melanoma
15 May 2014 7:30 am
RNS
Presents latest SCIB1 data at ASCO
09 May 2014 8:30 am
RNS
Directorate Change
01 May 2014 7:00 am
RNS
Dr Sally Adams to Join as Development Director
04 Apr 2014 7:00 am
RNS
Scancell to present SCIB1 at AACR
21 Mar 2014 7:00 am
RNS
8mg Higher Dose SCIB1 Study On Track
18 Feb 2014 7:00 am
RNS
Publication of Moditope Patent
11 Feb 2014 7:00 am
RNS
SCIB1 Granted FDA Orphan Drug Status
10 Feb 2014 4:43 pm
RNS
Holding(s) in Company
06 Jan 2014 7:00 am
RNS
Nottingham Technology Grant
16 Dec 2013 7:00 am
RNS
Nottingham Trent University Cancer Protein Study
12 Dec 2013 7:00 am
RNS
DNA ImmunoBody Patent Granted in Japan
11 Dec 2013 7:00 am
RNS
Director/PDMR Shareholding
09 Dec 2013 7:00 am
RNS
Half Yearly Report
  7:00 am
RNS
New data for SCIB1 in metastatic melanoma
18 Nov 2013 7:00 am
RNS
Re Agreement with Ichor
01 Nov 2013 4:56 pm
RNS
AGM Statement
22 Oct 2013 8:00 am
RNS
Director/PDMR Shareholding
14 Oct 2013 10:10 am
RNS
Holding(s) in Company
08 Oct 2013 2:54 pm
RNS
Notice of AGM
01 Oct 2013 7:00 am
RNS
Investor Update
24 Sep 2013 7:00 am
RNS
Investor Update Agenda
10 Sep 2013 3:06 pm
RNS
Investor Day
03 Sep 2013 7:00 am
RNS
DNA ImmunoBody Patent Granted in first market
20 Aug 2013 7:00 am
RNS
Inclusion on Frankfurt Stock Exchange
12 Aug 2013 5:16 pm
RNS
Director/PDMR Shareholding
08 Aug 2013 3:15 pm
RNS
Holding(s) in Company
05 Aug 2013 2:17 pm
RNS
Holding(s) in Company
01 Aug 2013 11:39 am
RNS
Result of General Meeting
26 Jul 2013 7:00 am
RNS
Result of Open Offer
23 Jul 2013 7:00 am
RNS
Director/PDMR Shareholding
19 Jul 2013 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
12 Jul 2013 7:00 am
RNS
Research Update
10 Jul 2013 10:55 am
RNS
Annual Financial Report
09 Jul 2013 7:00 am
RNS
Proposed Firm Placing and Open Offer
  7:00 am
RNS
Final Results
09 Apr 2013 7:00 am
RNS
Appointment of Non-Executive Director
14 Mar 2013 7:00 am
RNS
Re: The Journal of Clinical Investigation Paper
27 Feb 2013 2:00 pm
RNS
Directorate Change
06 Feb 2013 7:00 am
RNS
ImmunoBody patent approved for grant in Japan
 
Headlines
Top categories
Company finder
Forthcoming announcements